Showing results (311-320 of 354) with videos related to

Sort By:
Pageof 36
Frontiers in Oncology|July 1, 2021
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With OutcomesRui Jin, Ling Peng, Jiawei Shou, et al.
Oncotarget|April 19, 2016
Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsiesAdam E Frampton, Jonathan Krell, Mireia Mato Prado, et al.
The Lancet. Oncology|June 9, 2017
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialJustin Stebbing, Yauheni Baranau, Valeriy Baryash, et al.
Nucleic Acids Research|April 13, 2013
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsLoredana Pellegrino, Justin Stebbing, Vania M Braga, et al.
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Molecular Cancer Therapeutics|August 7, 2013
Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United StatesTakeru Wakatsuki, Melissa J LaBonte, Pierre O Bohanes, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2020
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19Jonathan T Sims, Venkatesh Krishnan, Ching-Yun Chang, et al.
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
Plos One|March 28, 2014
Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targetsDavid Britton, Yoh Zen, Alberto Quaglia, et al.
Liver Cancer|May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular CarcinomaAnthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.
Pageof 36